We are live on ! Find out more
RLYB icon

Rallybio

54 hedge funds and large institutions have $75.9M invested in Rallybio in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 11

43% more capital inflows, than outflows

Capital inflows: $8.7M | Capital outflows: $6.07M

1.47% more ownership

Funds ownership: 82.55% → 84.02% (+1.5%)

7% less funds holding

Funds holding: 58 → 54 (-4)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

Holders
54
Holders Change
-4
Holders Change %
-6.9%
% of All Funds
0.79%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
9
Increased
19
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

RLYB Hedge Fund Activity: Q4 2023 in Review

54 of the 6,878 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q4 2023, worth a combined $75.9M — down 28% from $105M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of RLYB and 9 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 19 added.

The largest buyer was Aberdeen Group, opening a new position worth an estimated $5.28M. The largest seller was Fidelity Investments, cutting an estimated $2.17M.

  • 54 institutional investors held Rallybio (RLYB) as of Q4 2023, down from 58 in Q3 2023.
  • Funds reported $75.9M of Rallybio stock for Q4 2023, down 28% quarter-over-quarter.
  • 9 funds opened new Rallybio positions in Q4 2023 and 12 closed out, a net change of -3 holders.
  • The largest Rallybio buyer in Q4 2023 was Aberdeen Group, an estimated $5.28M added.
  • The largest Rallybio seller in Q4 2023 was Fidelity Investments, an estimated $2.17M sold.

Based on aggregated 13F filings for Q4 2023.